Table 1 Overview of collected medicine samples, and results of analysis.
Region and country of collection | Sources of samples | Total no. of samples included | Results of analysis | ||||||
|---|---|---|---|---|---|---|---|---|---|
Private vendors or own stock | Health facilities | Donations or unknown | Informal vendors | No. of probably falsified samples | % | No. of probably substandard samples | % | ||
East Africa | 152 | 5 | 1 | 3 | 161 | 0 | 0.0% | 3 | 1.9% |
Kenya | 43 | 0 | 0 | 0 | 43 | 0 | 0.0% | 3 | 7.0% |
Rwanda | 9 | 0 | 0 | 0 | 9 | 0 | 0.0% | 0 | 0.0% |
Tanzania | 14 | 5 | 1 | 0 | 20 | 0 | 0.0% | 0 | 0.0% |
Uganda | 86 | 0 | 0 | 3 | 89 | 0 | 0.0% | 0 | 0.0% |
Central Africa | 1126 | 68 | 0 | 106 | 1300 | 31 | 2.4% | 48 | 3.7% |
Burundi | 241 | 1 | 0 | 0 | 242 | 0 | 0.0% | 7 | 2.9% |
Cameroon | 686 | 19 | 0 | 40 | 745 | 11 | 1.5% | 20 | 2.7 |
Central African Rep | 22 | 11 | 0 | 17 | 50 | 3 | 6.0% | 8 | 16.0% |
DR Congo | 142 | 11 | 0 | 10 | 163 | 6 | 3.7% | 3 | 1.8% |
Chad | 35 | 26 | 0 | 39 | 100 | 11 | 11.0% | 10 | 10.0% |
West Africa | 171 | 103 | 0 | 2 | 276 | 3 | 1.1% | 3 | 1.1% |
Ghana | 0 | 27 | 0 | 0 | 27 | 0 | 0.0% | 0 | 0.0% |
Nigeria | 171 | 76 | 0 | 2 | 249 | 3 | 1.2% | 3 | 1.2% |
Southern Africa | 78 | 29 | 11 | 0 | 118 | 0 | 0.0% | 0 | 0.0% |
Malawi* | 78 | 29 | 11 | 0 | 118 | 0 | 0.0% | 0 | 0.0% |
Southeast Asia | 64 | 0 | 0 | 0 | 64 | 0 | 0.0% | 0 | 0.0% |
India | 64 | 0 | 0 | 0 | 64 | 0 | 0.0% | 0 | 0.0% |
Total | 1,591 | 205 | 12 | 111 | 1919 | 34 | 1.77% | 54 | 2.81% |
